This open access journal publishes peer reviewed articles on clinical studies, real world evidence data, reviews, point of views, case series, and single clinical cases. The journal aim and scope encompasses clinical medicine, pharmacy, healthcare technology and other healthcare related disciplines with a focus on innovation in healthcare and policy. Articles may be in English, French, Italian and Spanish
Global and Regional Health Technology Assessment (GRHTA) is an international, peer-reviewed, open access journal focusing on promoting health technology assessment and economic evaluation, enabling choices among alternative therapeutical paths or procedures with different clinical and economic outcomes.
Drug Target Insights (DTI) is an international, peer-reviewed, open access journal, covering current developments in all areas of the field of clinical therapeutics and focusing on molecular drug targets which include disease-specific proteins, receptors, enzymes, and genes. The journal seeks to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life. The journal welcomes unsolicited article proposals. All articles are listed on PubMed and are freely available via PubMed Central.
Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies.
This journal will be available shortly.
Giornale di Clinica Nefrologica e Dialisi (GCND), formerly Giornale di Tecniche Nefrologiche e Dialitiche, is an online only, peer-reviewed, continuous publication journal addressing topics of interest for nephrologists, nephrology specialists, dialysis and transplant nephrology nurses, dialysis technicians, kidney dietitians and patients.
For the benefits of our readers, we host on this platform Cancer Breaking News, an open access peer reviewed journal promoting the debate and interaction between young physicians, leaders and qualified experts in oncology, published from 2013 to 2017.